US Stock MarketDetailed Quotes

ACST Acasti Pharma

Watchlist
  • 2.9000
  • +0.0600+2.11%
Close Jul 22 16:00 ET
  • 2.8400
  • -0.0600-2.07%
Post 17:33 ET
27.26MMarket Cap-2148P/E (TTM)

Acasti Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Acasti Pharma Earnings Date

Currency: USD

Period

Q4 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.43

+89.01%
Analyst Rating

Buy

Jul 1, 2024

Acasti Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 0.000--
--2025/Q1-- / 0.000--
--2024/Q40.000 / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 0.000--
--2025/Q1-- / 0.000--
--2024/Q40.000 / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--

Unlock Free Earnings Estimates

Acasti Pharma Earnings Reports

  • Acasti Pharma | 10-K: Annual report

    Jun 21 07:36 ET

  • Acasti Pharma | 10-Q: Quarterly report

    Feb 12 07:34 ET

  • Acasti Pharma: Q2 2024 Earnings Report

    Nov 13, 2023 07:30 ET

  • Acasti Pharma | 10-Q: Q1 2024 Earnings Report

    Aug 11, 2023 07:15 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 1, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg